Volume 19, Number 11—November 2013
Dispatch
Mayaro Virus Infection, Amazon Basin Region, Peru, 2010–2013
Table 1
Patient | Age, y/sex | Day of illness at enrollment | Isolation | RT-PCR† | IgM; IgG‡ |
||||
---|---|---|---|---|---|---|---|---|---|
Acute phase | Day 20 | Month 3 | Month 6 | Month 12 | |||||
1 | 12/F | 2 | MAYV | MAYV | 0; 0 | 6,400; 100 | 0; 6,400 | 0; 25,600 | 0; 25,600 |
2 | 28/F | 2 | MAYV | MAYV | 0; 0 | 1,600; 100 | 0; 1,600 | 0; 6,400 | 0; 25,600 |
3 | 19/F | 4 | Neg | Neg | 0; 0 | 6,400; 100 | 0; 1,600 | – | – |
4 | 11/M | 2 | MAYV | MAYV | 0; 0 | 1,600; 100 | 0; 1,600 | 0; 1,600 | 0; 6,400 |
5 | 41/F | 2 | MAYV | MAYV | 0; 0 | 25,600; 400 | 0; 1,600 | 0; 1,600 | 0; 6,400 |
6 | 20/M | 2 | Neg | Neg | 0; 0 | 6,400; 1,600 | 0; 1,600 | 0; 400 | – |
7 | 36/F | 1 | MAYV | MAYV | 0; 0 | 6,400; 100 | 0; 102,400 | 0; 409,600 | 0; 102,400 |
8 | 35/F | 1 | MAYV | MAYV | 0; 0 | 1,600; 100 | 400; 1,600 | 0; 25,600 | 0; 25,600 |
9 | 43/M | 2 | MAYV | MAYV | 0; 0 | 1,600; 0 | 0; 1,600 | 0; 6,400 | 0; 6,400 |
10 | 34/F | 3 | MAYV | MAYV | 0; 0 | 6,400; 100 | 0; 1,600 | 0; 6,400 | 0; 25,600 |
11 | 46/F | 3 | Neg | MAYV | 0; 0 | 1,600; 400 | 0; 6,400 | – | – |
12 | 51/M | 4 | Neg | Neg | 0; 0 | 6,400; 400 | 0; 1,600 | 0; 6,400 | 0; 6,400 |
13 | 40/F | 1 | MAYV | MAYV | 0; 0 | 1,600; 400 | 400; 25,600 | 0; 25,600 | 0; 25,600 |
14 | 11/M | 2 | MAYV | MAYV | 0; 0 | 1,600; 400 | 0; 25,600 | 0; 6,400 | 0; 6,400 |
15 | 11/M | 3 | MAYV | MAYV | 0; 0 | 1,600; 400 | 0; 6,400 | 0; 25,600 | 0; 25,600 |
16 | 64/M | 2 | Neg | MAYV | 0; 0 | 6,400; 25,600 | 400; 6,400 | 0; 6,400 | 0; 6,400 |
*MAYV, Mayaro virus; RT-PCR, reverse transcription PCR; Neg, negative; –, visits not attended by the patient.
†Isolation and RT-PCR results are from the acute-phase visit.
‡For ELISA IgM and IgG results, endpoint titration values were determined. All serology values are expressed as inverse titers.
Page created: October 31, 2013
Page updated: October 31, 2013
Page reviewed: October 31, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.